722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III

Haploidentical hematopoietic cell transplantation (Haplo-HCT) using ex vivo TCR-?B-Depleted grafts and upfront memory T-cell add-back mitigates the negative impact of pre-transplant measurable residual disease (MRD)

ACCELERATE A platform protocol to investigate post transplant cyclophosphamide based graft versus host disease prophylaxis in patients with hematologic malignancies undergoing mismatched unrelated donor peripheral blood stem cell transplantation

Chronic graft versus host disease after haploidentical transplantation in aplastic anemia Clinical characteristics risk factors and survival outcomes

Treatment of steroid refractory acute graft versus host disease by mesenchymal stromal cells The francophone society of bone marrow transplantation and cellular therapy SFGM TC experience in 43 patients

Propensity score matching analysis comparing the efficacy and treatment outcomes of belumosudil treatment with ruxolitinib therapy as second line or beyond in chronic GVHD patients after steroid failure

Observational comparison of orca T to registry based post transplant cyclophosphamide patients using matched unrelated donors

Donor derived sars cov 2 specific T cells to prevent COVID 19 early post allogeneic hematopoietic stem cell transplant

Real world effectiveness and safety of belumosudil in pediatric chronic graft versus host disease A retrospective cohort study

Propensity score matching analysis comparing the efficacy and long term outcomes of belumosudil to the best available treatment as a historical control used as second line therapy or beyond for chronic GVHD after steroid failure

Outcomes after bone marrow versus peripheral blood matched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide based gvhd prophylaxis

TFH subsets in patients after allogenic transplant are dysregulated prior to chronic GVHD development

FK506 improves B cell reconstitution after allo HSCT compared to csa A real world study

Safety and efficacy of post transplant cyclophosphamide vs tacrolimus plus methotrexate for gvhd prophylaxis in myelofibrosis

Dissecting complement pathway activation after allogeneic hematopoietic cell transplant Results of a monocentric longitudinal monitoring program

Axatilimab in combination with ruxolitinib in patients with newly diagnosed chronic graft versus host disease Interim safety analysis of a phase 2 randomized study

Efficacy and safety of the ROCK2 inhibitor belumosudil for chronic gvhd treatment Multicenter retrospective analysis of a large german austrian cohort of the belumosudil managed access program

Long term treatment duration and safety of axatilimab among patients with chronic graft versus host disease in AGAVE 201

Serum MMP 7 as an early and specific biomarker for hepatic graft versus host disease

Safety analysis of axatilimab in patients with chronic graft versus host disease in an expanded access program

An mRNA based cytomegalovirus vaccine induces robust T cell immune responses in cytomegalovirus seropositive adults who have undergone allogeneic hematopoietic cell transplantation

Immune and DNA damage responses in the intestinal stroma of patients presenting with lower gastro intestinal symptoms after allogeneic stem cell transplantation

Impact of anti thymocyte globulin on graft versus host disease risk among HLA matched related donors undergoing allogeneic hematopoietic cell transplantation for aplastic anemia

Response dynamics to belumosudil in chronic graft versus host disease Characterizing late responses and organ specific response expectations from the rockstar study